CIPLA Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
18,801
16,543
17,270
12,222
16,695
Depreciation, Depletion & Amortization
3,726
5,047
7,542
8,715
9,498
Other Funds
-
123
14
-
-
Funds from Operations
20,688
17,565
20,180
19,990
21,614
Changes in Working Capital
5,619
7,186
4,294
2,354
7,833
Net Operating Cash Flow
15,070
10,379
15,886
22,345
13,782
Capital Expenditures
5,696
6,462
10,769
11,360
8,162
Sale of Fixed Assets & Businesses
29
206
1,947
1,540
2,193
Purchase/Sale of Investments
17,972
609
1,706
634
1,792
Net Investing Cash Flow
13,425
9,730
45,315
12,267
9,313
Cash Dividends Paid - Total
1,606
1,879
1,809
1,936
1,893
Issuance/Reduction of Debt, Net
433
5,078
34,418
10,803
345
Net Financing Cash Flow
1,173
3,322
32,652
12,619
2,236
Net Change in Cash
322
3,885
3,123
2,478
2,431
Free Cash Flow
9,374
3,917
5,117
10,985
5,620
Net Assets from Acquisitions
25,785
4,129
34,820
1,879
583
Other Sources
54
60
32
72
60
Change in Capital Stock
-
-
29
120
1
Exchange Rate Effect
151
86
99
63
198
Other Uses
-
14
-
6
1,028

About CIPLA

View Profile
Address
Cipla House, Peninsula Business Park
Mumbai Maharashtra 400013
India
Employees -
Website http://www.cipla.com
Updated 09/14/2018
Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the Pharmaceuticals and New Ventures segments. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients.